Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
72.1M
-
Number of holders
-
73
-
Total 13F shares, excl. options
-
24.8M
-
Shares change
-
+2.86M
-
Total reported value, excl. options
-
$57.4M
-
Value change
-
-$5.6M
-
Put/Call ratio
-
7.28
-
Number of buys
-
50
-
Number of sells
-
-33
-
Price
-
$2.31
Significant Holders of Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) as of Q4 2020
101 filings reported holding OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share as of Q4 2020.
Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) has 73 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.8M shares
of 72.1M outstanding shares and own 34.46% of the company stock.
Largest 10 shareholders include BVF INC/IL (4.52M shares), BlackRock Inc. (3.41M shares), VANGUARD GROUP INC (3.11M shares), Vivo Capital, LLC (1.25M shares), UBS Group AG (1.03M shares), BAKER BROS. ADVISORS LP (956K shares), CHI Advisors LLC (827K shares), STATE STREET CORP (739K shares), RENAISSANCE TECHNOLOGIES LLC (711K shares), and AXA S.A. (620K shares).
This table shows the top 73 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.